AML/MDS Drug Sensitization by in Vivo Chemotherapy Administration
Last updated on July 2021Recruitment
- Recruitment Status
- Recruiting
- Estimated Enrollment
- Same as current
Summary
- Conditions
- Acute Myeloid Leukemia
- Myelodysplastic Syndromes
- Type
- Observational
- Design
- Observational Model: CohortTime Perspective: Prospective
Participation Requirements
- Age
- Between 18 years and 125 years
- Gender
- Both males and females
Description
Not Provided
Not Provided
Tracking Information
- NCT #
- NCT04263181
- Collaborators
- Notable Labs
- Investigators
- Principal Investigator: John Welch, M.D., Ph.D. Washington University School of Medicine